The panel agreed that multidisciplinary rehabilitation teams should work with people to make a plan for their rehabilitation once any symptoms had been investigated that could affect the safety of rehabilitation. Physical, psychological and psychiatric aspects of rehabilitation should be addressed, with fatigue management being a key component of this. The evidence showed that breathlessness, fatigue and ‘brain fog’ are among the most commonly reported long‑term symptoms, so support for these should be part of the person’s rehabilitation plan. See also the recommendations on multidisciplinary rehabilitation teams in Section 9.
Multidisciplinary rehabilitation
Related information: Clinical case definitions
A personalised rehabilitation and management plan records the person’s needs and how they will be met. In some settings a ‘rehabilitation prescription’ may be used to capture this information. The rehabilitation prescription is held by the person and includes an individualised description of rehabilitation needs or recommendations to inform the future planning and delivery of a person’s ongoing rehabilitation. The panel recognised that some people may need additional support, such as an interpreter or advocate, in developing the rehabilitation and management plan.
For the November 2021 update, the panel reviewed evidence that emphasised the fluctuating nature of ongoing symptomatic COVID-19 and post-COVID-19 syndrome. Based on this evidence, the panel agreed that it was key that a management plan should take into account that symptoms may fluctuate.
Rehabilitation: a set of interventions designed to optimise functioning, health and wellbeing, and reduce disability in people with health conditions in interaction with their environment. In the context of ongoing COVID-19 symptoms, this may include providing information, education, supported self-management, peer support, symptom management strategies and physical rehabilitation. (Informed by the World Health Organization's fact sheet on rehabilitation.)
Full details of the evidence and the panel's discussion are in the evidence reviews on: |